CAJ | 학술논문

目的：观察参松养心胶囊治疗老年人室性期前收缩的临床疗效和安全性。方法老年（＞65岁）冠心病伴室性期前收缩患者（＞30 h-1）132例，随机分为2组。在常规治疗的基础上，对照组（64例）采用心律平治疗，治疗组（68例）采用参松养心胶囊治疗，疗程均为8周。比较2组治疗后的疗效及治疗前后24 h动态心电图室性期前收缩数量。动态心电图期前收缩数量减少50%为临床好转。结果治疗组室性期前收缩总有效率为88.2%，对照组为73.5%，2组治疗后室性期前收缩疗效比较差异有统计学意义（χ2=6.810，P＜0.05）。治疗组临床症状总有效率为89.7%，对照组为76.6%，2组比较差异有统计学意义（χ2=7.030，P＜0.05）。结论参松养心胶囊治疗老年冠心病伴发室性期前收缩可有效减少室性期前收缩数量，且无明显不良反应。
목적：관찰삼송양심효낭치료노년인실성기전수축적림상료효화안전성。방법노년（＞65세）관심병반실성기전수축환자（＞30 h-1）132례，수궤분위2조。재상규치료적기출상，대조조（64례）채용심률평치료，치료조（68례）채용삼송양심효낭치료，료정균위8주。비교2조치료후적료효급치료전후24 h동태심전도실성기전수축수량。동태심전도기전수축수량감소50%위림상호전。결과치료조실성기전수축총유효솔위88.2%，대조조위73.5%，2조치료후실성기전수축료효비교차이유통계학의의（χ2=6.810，P＜0.05）。치료조림상증상총유효솔위89.7%，대조조위76.6%，2조비교차이유통계학의의（χ2=7.030，P＜0.05）。결론삼송양심효낭치료노년관심병반발실성기전수축가유효감소실성기전수축수량，차무명현불량반응。
Objective To observe the therapeutic effect and safety of Shensongyangxin capsule on senile arrhythmia. Methods 132 cases of elderly (>65 years old) in patients with coronary heart disease and ventricular premature beat (>30 h-1), were randomly divided into 2 groups: propafenone in the treatment group (64 cases), Shensongyangxin capsule treatment group (68 cases). The treatment course was 8 weeks, before and after the treatment of 24 h dynamic electrocardiogram room prematurenumber. The number of dynamic ECG beats was 50% reduction for clinical improvement. Results The total effective rate of Premature ventricular contractions in treatment group was 88.2%, which was 73.5% in control group. There was a significant difference between two groups (χ2=6.810,P<0.05). The total effective rate of clinal symptoms in treatment group was 89.7%, which was 76.6% in control group. There was a significant difference between two groups (χ2=7.030,P<0.05). Conclusion Shensongyangxin capsule combined with western drugs is safe, simple and effective in treating semile ventricular premature beat caused by coronary atherosclerotic heart disease.